BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Umemura T, Matsumoto A, Tanaka E. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis. World J Gastroenterol 2018; 24(13): 1440-1450 [PMID: 29632425 DOI: 10.3748/wjg.v24.i13.1440]
URL: https://www.wjgnet.com/1007-9327/full/v24/i13/1440.htm
Number Citing Articles
1
Naoyuki Fujimori, Naoki Tanaka, Takefumi Kimura, Kenji Sano, Akira Horiuchi, Naoyuki Kato, Yoshiyuki Takahashi, Naoya Kuribayashi, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitusClinical Journal of Gastroenterology 2020; 13(1): 83 doi: 10.1007/s12328-019-01018-1
2
Fu-Rong Sun, Bing-Yuan Wang. Alcohol and Metabolic-associated Fatty Liver DiseaseJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00173
3
Wasit Wongtrakul, Sorachat Niltwat, Phunchai Charatcharoenwitthaya. The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.744713
4
Michelle T. Long, Joseph M. Massaro, Udo Hoffmann, Emelia J. Benjamin, Timothy S. Naimi. Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology 2020; 18(8): 1831 doi: 10.1016/j.cgh.2019.11.022
5
Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Tomoo Yamazaki, Takahito Katsuyama, Yuichi Iwashita, Jonathan Pham, Satoru Joshita, Sai P. Pydi, Takeji Umemura. Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLDLiver International 2021; 41(3): 505 doi: 10.1111/liv.14776
6
Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Kenji Sano, Akira Horiuchi, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Miglitol attenuates non-alcoholic steatohepatitis in diabetic patientsHepatology Research 2018; 48(13): 1092 doi: 10.1111/hepr.13223
7
Shogo Takahashi, Naoki Tanaka, Tatsuki Fukami, Cen Xie, Tomoki Yagai, Donghwan Kim, Thomas J. Velenosi, Tingting Yan, Kristopher W. Krausz, Moshe Levi, Frank J. Gonzalez. Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor DevelopmentHepatology Communications 2018; 2(12): 1567 doi: 10.1002/hep4.1263
8
Fredrik Åberg, Martti Färkkilä, Ville Männistö. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological StudiesAlcoholism: Clinical and Experimental Research 2020; 44(2): 384 doi: 10.1111/acer.14271
9
Yu-Hyeon Yi, Yun-Jin Kim, Sang-Yeoup Lee, Byung-Mann Cho, Young-Hye Cho, Jeong-Gyu Lee. Health behaviors of Korean adults with hepatitis B: Findings of the 2016 Korean National Health and Nutrition Examination SurveyWorld Journal of Gastroenterology 2018; 24(28): 3163-3170 doi: 10.3748/wjg.v24.i28.3163
10
Grażyna Kubiak-Tomaszewska, Piotr Tomaszewski, Jan Pachecka, Marta Struga, Wioletta Olejarz, Magdalena Mielczarek-Puta, Grażyna Nowicka. Molecular mechanisms of ethanol biotransformation: enzymes of oxidative and nonoxidative metabolic pathways in humanXenobiotica 2020; 50(10): 1180 doi: 10.1080/00498254.2020.1761571
11
Hannes Hagström, Stergios Kechagias, Mattias Ekstedt. Risk for hepatic and extra‐hepatic outcomes in nonalcoholic fatty liver diseaseJournal of Internal Medicine 2021;  doi: 10.1111/joim.13343
12
Xiaojing Wang, Naoki Tanaka, Xiao Hu, Takefumi Kimura, Yu Lu, Fangping Jia, Yoshiko Sato, Jun Nakayama, Kyoji Moriya, Kazuhiko Koike, Toshifumi Aoyama. A high-cholesterol diet promotes steatohepatitis and liver tumorigenesis in HCV core gene transgenic miceArchives of Toxicology 2019; 93(6): 1713 doi: 10.1007/s00204-019-02440-7
13
Min Yao, Wenjie Zheng, Li Wang, Miao Fang, Zhizhen Dong, Dengfu Yao. Neoplasm2018;  doi: 10.5772/intechopen.77400
14
Shen Li, Antonio Saviano, Derek J. Erstad, Yujin Hoshida, Bryan C. Fuchs, Thomas Baumert, Kenneth K. Tanabe. Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational ChallengesJournal of Clinical Medicine 2020; 9(12): 3817 doi: 10.3390/jcm9123817
15
Daniel Q. Huang, Hashem B. El-Serag, Rohit Loomba. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and preventionNature Reviews Gastroenterology & Hepatology 2021; 18(4): 223 doi: 10.1038/s41575-020-00381-6
16
Elif Inan-Eroglu, Bo-Huei Huang, Matthew N. Ahmadi, Nathan Johnson, Emad M. El-Omar, Emmanuel Stamatakis. Joint associations of adiposity and alcohol consumption with liver disease-related morbidity and mortality risk: findings from the UK BiobankEuropean Journal of Clinical Nutrition 2021;  doi: 10.1038/s41430-021-00923-4
17
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
18
Francesca Cainelli, Titya Thao, Carolyne Pung, Sandro Vento. Alcohol? Not for Non-alcoholic Fatty Liver Disease PatientsFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00014
19
Pan Diao, Xiaojing Wang, Fangping Jia, Takefumi Kimura, Xiao Hu, Saki Shirotori, Ibuki Nakamura, Yoshiko Sato, Jun Nakayama, Kyoji Moriya, Kazuhiko Koike, Frank J Gonzalez, Toshifumi Aoyama, Naoki Tanaka. A saturated fatty acid-rich diet enhances hepatic lipogenesis and tumorigenesis in HCV core gene transgenic miceThe Journal of Nutritional Biochemistry 2020; 85: 108460 doi: 10.1016/j.jnutbio.2020.108460
20
Xiao Hu, Xiaojing Wang, Fangping Jia, Naoki Tanaka, Takefumi Kimura, Takero Nakajima, Yoshiko Sato, Kyoji Moriya, Kazuhiko Koike, Frank J Gonzalez, Jun Nakayama, Toshifumi Aoyama. A trans-fatty acid-rich diet promotes liver tumorigenesis in HCV core gene transgenic miceCarcinogenesis 2020; 41(2): 159 doi: 10.1093/carcin/bgz132